Harel Insurance Investments & Financial Services’s Capricor Therapeutics CAPR Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio CAPR Stock Details CAPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17K	Hold	689	–	–	﹤0.01%	506
2026 Q1	$21K	Hold	689	–	–	﹤0.01%	471
2025 Q4	$20K	Hold	689	–	–	﹤0.01%	389
2025 Q3	$5K	Hold	689	–	–	﹤0.01%	451
2025 Q2	$7K	Hold	689	–	–	﹤0.01%	411
2025 Q1	$7K	Hold	689	–	–	﹤0.01%	445
2024 Q4	$10K	Hold	689	–	–	﹤0.01%	425
2024 Q3	$10K	Hold	689	–	–	﹤0.01%	451
2024 Q2	$3K	Hold	689	–	–	﹤0.01%	524
2024 Q1	$5K	Hold	689	–	–	﹤0.01%	512
2023 Q4	$3K	Hold	689	–	–	﹤0.01%	580
2023 Q3	$2K	Hold	689	–	–	﹤0.01%	637
2023 Q2	$3K	Hold	689	–	–	﹤0.01%	669
2023 Q1	$3K	Hold	689	–	–	﹤0.01%	684
2022 Q4	$3K	Hold	689	–	–	﹤0.01%	663
2022 Q3	$4K	Hold	689	–	–	﹤0.01%	674
2022 Q2	$2K	Hold	689	–	–	﹤0.01%	696
2022 Q1	$2K	Hold	689	–	–	﹤0.01%	683
2021 Q4	$2K	Hold	689	–	–	﹤0.01%	730
2021 Q3	$3K	Hold	689	–	–	﹤0.01%	661
2021 Q2	$4K	Hold	689	–	–	﹤0.01%	750
2021 Q1	$3K	Hold	689	–	–	﹤0.01%	726
2020 Q4	$2K	Hold	689	–	–	﹤0.01%	703
2020 Q3	$4K	Hold	689	–	–	﹤0.01%	602
2020 Q2	$3K	Hold	689	–	–	﹤0.01%	490
2020 Q1	$1K	Hold	689	–	–	﹤0.01%	421
2019 Q4	$1K	Hold	689	–	–	﹤0.01%	458
2019 Q3	$3K	Sell	689 -7	-1%	-$24	﹤0.01%	476
2019 Q2	$2K	Hold	696	–	–	﹤0.01%	454
2019 Q1	$3K	Hold	696	–	–	﹤0.01%	431
2018 Q4	$3K	Hold	696	–	–	﹤0.01%	439
2018 Q3	$7K	Hold	696	–	–	﹤0.01%	454
2018 Q2	$9K	Hold	696	–	–	﹤0.01%	432
2018 Q1	$9K	Hold	696	–	–	﹤0.01%	423
2017 Q4	$11K	Hold	696	–	–	﹤0.01%	424
2017 Q3	$21K	Hold	696	–	–	﹤0.01%	341
2017 Q2	$6K	Hold	696	–	–	﹤0.01%	412
2017 Q1	$24K	Hold	696	–	–	﹤0.01%	303
2016 Q4	$23K	Hold	696	–	–	﹤0.01%	244
2016 Q3	$23K	Hold	696	–	–	﹤0.01%	291
2016 Q2	$27K	Hold	696	–	–	﹤0.01%	421
2016 Q1	$18K	Hold	696	–	–	﹤0.01%	289
2015 Q4	$21K	Buy	+696	New	+$27.7K	﹤0.01%	249

Other funds holding CAPR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

DCM

DG Capital Management New York $475M AUM 36.12% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Harel Insurance Investments & Financial Services's CAPR Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services held its Capricor Therapeutics (CAPR) position steady in Q2 2026 at 689 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #506.

Harel Insurance Investments & Financial Services first reported a position in CAPR in Q4 2015 and has held it in 43 quarters since. The position peaked at $27K in Q2 2016. 78 funds tracked by Wall St. Rank hold CAPR as of Q2 2026.

Harel Insurance Investments & Financial Services held 689 shares of Capricor Therapeutics worth $17K as of Q2 2026.
Harel Insurance Investments & Financial Services left its Capricor Therapeutics share count unchanged in Q2 2026.
Capricor Therapeutics made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #506 holding.
Harel Insurance Investments & Financial Services first reported a position in Capricor Therapeutics in Q4 2015 and has held it in 43 quarters since.
Harel Insurance Investments & Financial Services's Capricor Therapeutics position peaked at $27K in Q2 2016.
78 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.